Académique Documents
Professionnel Documents
Culture Documents
Progestin and
Hormonal Contraseption
Dr. Rika Yuliwulandari, PhD
CH3 O
CH3 OH
OH
HO
HO
Estradiol
Intramuscular (100%)
(estr-1,3,5-triene-3,17b-diol)
HO
Estrone
intramuscular (33%)
(3-hydroxy-estr-1,3,5-triene-17-one)
Natural Progestin
O
CH3
CH3
Progesterone
(Pregn-4-ene-3,20-dione)
CH3
Estriol
oral (1.6%)
(?????)
H3C
CH3
CH3
CH3
HO
HO
cholesterol
CH3 OH
CH3
CH3
CH3
HO
CH3 OH
pregnenolone
testosterone
estradiol
H3C
CH3
progesterone
CH3 O
CH3
HO
O
CH3
OH
CH3
CH3
HO
CH3
OH
5b-metabolite
20a/b-hydroxy
metabolite
CH3
CH3 OH
CH3
CH3
estrone
H3C
H3C
OH
HO
O
OH
6a-hydroxy
metabolite
estriol
Ovulation
ESTROGEN
Pharmacology
Function:
Estrogen like:
Flavon, isoflavon, chumesthan
derivate
Carcinogen
Early studies tumors of breast, uterus, testis,
bone, kidney
Estrogen progestin combination standard
practice now:
Increased total risk of breast cancer by 24%
Theory:
Carcinogenic actions due to trophic effects (cell
proliferation effects)
Alternate theory conversion to quinones ROS
8
DNA damage
Pharmacokinetic
Absorption:
GI tr, mucose, intact skin
Po, iv: absorption fast and complete
Dissolve in oil
Inactivation: liver
Excretion: gall bladder--- enterohepatic cycle -- ren
Woman:
Half cycle: 25-100 ug/day
Luteal phase: 10-80 mg/day
Menopause: 5-10 ug/day
Therapeutic Uses
Combination oral contraceptives:
Block ovulation
Menopausal Hormone Therapy (MHT):
Secondary effects of decreased
hormones hot flashes, bone loss,
vaginitis atropicans,
Estrogen/Progestin dependent
cancers: antagonism of ER and PR
Abortifacients: induction of uterine
contractions
Other uses
Prostate ca:
Estrogen block androgen production
Chlorothianizan: palliative tx
Posology
Estradiol tab: 1, 2 mg
Estradiol benzoat, valerate,
cipionate inj im slow release: 05
mg/ml; 10, 20, 40 mg/ml; 5 mg.ml
Diethylstilbestrol: 0.1; 0.25; 0,5; 1;
5 mg
Ethynil estradiol tab: 0.02-0.5 mg
Chlorothianizen caps: 12, 25 mg
11
Estrogen dose
Premenopausal syndrome:
Conjugated estrogen: 0.3-1.25 mg/day
Ethynil estradiol: 0.01-0.02 mg/day
21-25 days
Can be + MPA (Medroxy progesterone
acetate) 10 mg/day at day 10-14 ---
endometrium ca
If estrogen KI: MPA inj. 150 mg/month
Osteoporosis:
Ethynil estradiol 15 ug/day
12
Equivalency:
50 ug estradiol ~ 50 ug
ethynilestradiol ~ 80 ug mestranol ~
5 mg diethylstilbestrol ~ 5 mg
conjugated estrogen
Drug of choice:
Price
Individual situation
Po
13
Side effect
Nausea, vomitus
Anorexia, headache
Pain and tenderness of mammae
Oedem ---- high dose
14
Synthetic Estrogenic
Estradiol look-alikes .. agonists
CH3 OH
H3C
CH3 OH
HO
HO
HO
CH3 OH
CH3 OH
HO
HO
OH
HO
HO
CH3 OH
CH3 OH
HO
Synthetic Estrogenic
Diethyl-Stilbestrols (DES)
CH3 OH
C
H 2C
CH
HO
RO
Ethinyl-estradiol R = H
Mestranol R = CH3
Cl
MeO
OH
CH2
Diethylstilbestrol
OMe
H 3C CH
HO
OMe
Chlorotrianisene
H 3C
CH3
C CH
3
H
Dienestrol
OH
ANTI ESTROGEN
17
Estrogen Antagonists
Triphenylethylene Derivatives Inverse Agonists
Cl
Cl
OCH2CH2 N(CH2CH3)2
CH3
OCH2CH2N(CH2CH3)2
OCH2CH2 N(CH2CH3)2
Tamoxiphen
R=H
4-Hydroxy tamoxiphen R = OH
Zuclomiphene
Enclomiphene
OMe
Cl
MeO
OMe
Chlorotrianisene
(estrogenic)
H3C
O
N
CH3
OH
HO
Raloxifene
Cl
HO
Nafoxidine
Toremifene
Anti estrogen
Inhibit estrogen work
Progestin, androgen
20
Clomifen
Rat:
Weak estrogenic
Moderate anti estrogenic
21
Absorption
Po: good,
50% is excreted via urine 5 days post intake
Block negative feedback of estrogen to
adenohypophysis --- secretion of estrogen ---cyst or ovarium enlargement in clomifen tx
Palliative tx in ca mammae
22
Tamoxifen
Anti estrogen effect
Competitive inhibitor in estrogen receptor
Decrease number of receptor
Pharmacokinetic
Uses:
Palliative tx in breast ca post menopause
Posology:
Tab 10 mg
23
PROGESTINE
24
Progesterone types
Natural progesterone
Synthesis: ovarium, luteal corpus,
adrenal cortex, testis, placenta
Modification of testosterone, without
C19 atom
Production:
Synthetic progesterone
(progestine derivative)
25
CH3
CH3
CH3
OCO(CH2)4CH3
CH3
CH3
Derivatize ring D
17a-hydroxy progesterone
caproate
Progesterone
CH3
CH3
OCOCH3
Medroxyprogesterone acetate
Megestrol CH3
acetate
CH3
OCOCH3
CH3
O
CH3
CH3
OCOCH3
CH3
CH3
CH3
O
Cl
Chlormadinone
acetate
CH3 OH
Testosterone Derivatives
CCH3
CH
CH3
CH3
O
CH3
Dimethisterone
Ethisterone
19-Nor-testosterone Derivatives
HO N
Norethisterone
Norethindrone
Norgestimate
OH
CH
CH
H3C
OCOCH3
CH
CH
H3C
CH3 OH
CH3 OH
Norgestrel
Pharmacology
Luteal phase of endometrium
Decrease secretion of secret in
endocervical gland
Make the secret thicker
In pregnancy: (prevent uterus
contractility)
Pharmacokinetic
Progesteron
In oil ---- well absorbed
Po ---- well absorbed, esp. synthetic
28
Uses:
Contraception
Combined with estrogen
MPA, noretindron enantate ---- long term
contraception
29
PROGESTERONE
ANTAGONIST
30
Progesterone Antagonist
CH3
H3C
CH3
N
CH3 OH
Mifepristone
(RU-486)
(not the morning-after pill)
H3C
N
CH3 OH
CCH3
CH2CH2CH2OH
Onapristone
HORMONAL
CONTRACEPTION
32
LH stimulates:
Ovulation (36 hrs after LH
surge)
FSH stimulates:
Folliculogenesis
Estradiol production
Estradiol:
Initial negative feedback on
hypothalamus and pituitary
Endometrial proliferation
When high enough long
enough, switches to
positive feedback resulting
in LH secretion
Progesterone:
Elevation indicative of
ovulation
Pro-pregnancy
Inhibits LH & FSH
Progesterone:
Creates thick cervical mucus to prevent
sperm penetration
Impairs normal tubal motility and peristalsis
Prevents ovulation
Thickens mucous in cervix
Thins endometrium
35
Contraception
Po, inj, intra vaginal, intra uterine,
condom, tubectomi, vasectomi
topical: spermicid
Implantasi subcutan, patch
36
Oral contraception
Combination, sequential, mini pill,
morning after pill
Primary Use
Prevent pregnancy
Secondary Uses
Heavy or irregular menstruation
Endometriosis
polycystic ovary syndrome
dysfunctional uterine bleeding
37
Alesse
Brevicon
Cyclessa
Demulen
Desogen
Estrostep
Genora
Intercon
Jenest
Levlen
Levlite
Levora
Loestrin
Lo/Ovral
Mircette
ModiCo
Necon
N.E.E.
Nelova
Nordette
Norethin
Norinyl
Ortho-Cept
Ortho-Cyclen
Ortho-Novum
Ortho Tri-Cyclen
Ovcon
Ovral
Tri-Levlen
Tri-Noriny
Triphasil
Trivora
Zovia
39
Progestins
Biphasic Pills
Mircette: low estrogen, high
progestin, low androgen
Ortho-Novum 10/11: high estrogen,
medium progestin, low/medium
androgen
Hormonal contraception. Pharmacists Letter/Prescribers
Letter 2006; 22 (8):220809.
Triphasic Pills
Estrostep Fe: low estrogen, high progestin,
medium androgen
Ortho Tri-Cyclen Lo: low estrogen, low
progestin, low androgen
Cyclessa: low estrogen, high progestin, low
androgen
Triphasil: medium estrogen, low progestin,
low/medium androgen
Ortho Tri-Cyclen: medium estrogen, low
progestin, low androgen
Tri-Norinyl, Ortho-Novum 7/7/7: medium
estrogen, medium progestin, low/medium
androgen
Emergency Contraception
Plan B: high progestin x 2 pills
(levonorgestrel 0.75 mg each)
Women presenting w/in 72 hrs of
unprotected intercourse or contraceptive
failure (89% effective), consider for up to 5
days following unprotected intercourse
Hormonal contraception. Pharmacists Letter/Prescribers
Letter 2006; 22 (8):220809.
Weight
Sexual desire
Vaginal discharge
Menstrual flow
Breast size
Blood pressure
complexion
Breakthrough bleeding
Nausea headaches
Urinary tract infection
Depression
Gum inflammation
47
Contraceptive vaccines
Vaginal rings
Intrauterine Contraception
Cervical caps
Transdermal patch
Implants and injectables
48
Effect of contraception
Reproductive organ
Ovarium: function (reversible)
Uterus: histological changes
myometrium hypertrophy, oedem
Phalopian tube: function (reversible)
Cervix: secret changes
Mammarian gland: enlarge mamm
gland, estrogen prevents lactation
Menstrual cycle: disturbance
Other effects: liver function,
metabolism carbohydrate, fat,
49
protein
Side Effects
Too much ESTROGEN
Early/mid-cycle breakthrough
bleeding, spotting,
hypomenorrhea
Dysmenorrhea
Iron deficiency anemia
Ectopic pregnancy (COC pill only)
Ovarian cysts (higher dose estrogen pills only)
Ovarian cancer
Endometrial cancer
Increased bone density
Acne
Ortho Tri-Cyclen and Estrostep FDA-labeled for
treatment of acne*
Absolute Contraindications
Known pregnancy
Breast or uterine cancer
Thromboembolic event or stroke
Hepatitis
Severe hypertension
Thrombophlebitis
Hyperlipidemia
Anemia haemolytic chronic
Ca mammae or genital, severe
mental deppression
53